Conversely, expression of other markers was significantly less frequent in AMKL versus non-AMKL patients, including HLADR, CD13, CD123 and expression of the lineage commitment antigens CD11b, CD15, CD64, CD14, CD300e and CD203c (Table 2). Here, FCGR1A is linked to acute megakaryoblastic leukemia.